COMBINATION CHEMOTHERAPY FOR MULTIPLE-MYELOMA WITH MELPHALAN, IFOSFAMIDE, PREDNISOLONE, NITROSOUREA AND VINCRISTINE

被引：0
|
作者：
ISHII, H
机构：
来源：
ACTA MEDICA OKAYAMA | 1988年 / 42卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：175 / 182
页数：8
相关论文
共 50 条
  • [1] M-PROTEIN KINETICS IN MULTIPLE-MYELOMA TREATED WITH MELPHALAN, IFOSFAMIDE, PREDNISOLONE, NITROSOUREA AND VINCRISTINE IN COMBINATION
    ISHII, H
    ACTA MEDICA OKAYAMA, 1988, 42 (05) : 279 - 286
  • [2] PROGNOSTIC FACTORS IN MULTIPLE-MYELOMA TREATED WITH PREDNISOLONE AND SEQUENTIAL MELPHALAN AND IFOSFAMIDE - MIP COMBINATION CHEMOTHERAPY
    ADACHI, T
    ASANO, K
    SEZAKI, T
    TAKAHASHI, I
    KIMURA, I
    ACTA MEDICA OKAYAMA, 1982, 36 (01) : 39 - 47
  • [3] VINCRISTINE, CYCLOPHOSPHAMIDE, MELPHALAN, PREDNISOLONE (VCMP) CHEMOTHERAPY OF MULTIPLE-MYELOMA AFTER INEFFECTIVE MELPHALAN, PREDNISOLONE (MP) THERAPY
    GLUCK, S
    SCHOPPE, WD
    SCHNEIDER, W
    BLUT, 1986, 53 (03): : 227 - 227
  • [4] COMBINATION CHEMOTHERAPY VERSUS MELPHALAN AND PREDNISOLONE IN THE TREATMENT OF MULTIPLE-MYELOMA - AN OVERVIEW OF PUBLISHED TRIALS
    GREGORY, WM
    RICHARDS, MA
    MALPAS, JS
    JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (02) : 334 - 342
  • [5] MULTIPLE-MYELOMA TREATED WITH MITOXANTRONE IN COMBINATION WITH VINCRISTINE AND PREDNISOLONE (NOP REGIMEN) VERSUS MELPHALAN AND PREDNISOLONE - A PHASE-III STUDY
    KELDSEN, N
    BJERRUM, OW
    DAHL, IMS
    DRIVSHOLM, A
    ELLEGAARD, J
    GADEBERG, O
    GIMSING, P
    GRONVOLD, T
    HANSEN, MM
    HIPPE, E
    LAMVIK, J
    LY, B
    SKARBOVIK, A
    TALSTAD, I
    THORLING, K
    WESENBERG, K
    WISLOFF, F
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1993, 51 (02) : 80 - 85
  • [6] COMBINATION CHEMOTHERAPY FOR MULTIPLE-MYELOMA WITH BCNU, CYCLOPHOSPHAMIDE, VINCRISTINE, MELPHALAN, AND PREDNISONE (M-2 PROTOCOL)
    CASE, DC
    SONNEBORN, HL
    PAUL, SD
    HAYES, DM
    DORSK, BM
    CARROLL, RJ
    BOVE, L
    ONCOLOGY, 1985, 42 (03) : 137 - 140
  • [7] INTERMITTENT MELPHALAN PREDNISOLONE THERAPY OF MULTIPLE-MYELOMA
    BRAUN, HJ
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1972, 97 (03) : 84 - &
  • [8] COMBINATION CHEMOTHERAPY FOR MULTIPLE-MYELOMA WITH MELPHALAN, PREDNISONE, CYCLOPHOSPHAMIDE, VINCRISTINE, AND CARMUSTINE (BCNU) (M-2 PROTOCOL)
    TIRELLI, U
    CRIVELLARI, D
    CARBONE, A
    VERONESI, A
    GALLIGIONI, E
    TROVO, MG
    TUMOLO, S
    GRIGOLETTO, E
    CANCER TREATMENT REPORTS, 1982, 66 (11): : 1971 - 1973
  • [9] COMBINATION CHEMOTHERAPY WITH MCNU, VINDESINE, MELPHALAN, AND PREDNISOLONE (MCNU-VMP THERAPY) IN INDUCTION THERAPY FOR MULTIPLE-MYELOMA
    IMAMURA, Y
    TAKAGI, T
    YAWATA, Y
    NISHINARITA, S
    KOSAKA, M
    MIKUNI, C
    TAKATSUKI, K
    SEZAKI, T
    MORI, M
    TSUCHIYA, J
    SATO, N
    ISOBE, T
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 1994, 59 (02) : 113 - 123
  • [10] COMBINATION CHEMOTHERAPY WITH VINCRISTINE, DOXORUBICIN, DEXAMETHASONE FOR REFRACTORY OR RELAPSING MULTIPLE-MYELOMA
    MONCONDUIT, M
    LELOET, X
    BERNARD, JF
    MICHAUX, JL
    BRITISH JOURNAL OF HAEMATOLOGY, 1986, 63 (03) : 599 - 601
12345